Alamar Biosciences Stock
Alamar Biosciences is at the forefront of precision proteomics with its platform designed to enhance protein analysis and cancer detection. The company's advanced antibody technologies aid in the early diagnosis and potential treatment of diseases, contributing to breakthroughs in biomarker discovery and disease prevention.
Management Team
| YULING LUO, PHD Founder, Chairman & CEO |
| TOD WHITE, JD CFO/CBO |
| STEVE CHEN, PHD Founder, COO |
| XIAO-JUN MA, PHD CTO |
| YIYUAN YIN, PHD Founder, VP of Technology |
